Nasal Spray Market is expected to expand at a moderate CAGR of over 6.1% over the next ten years, and be valued at more than US$ 3.21 Billion by 2030

[250 Pages Report] Nasal Spray Market is expected to expand at a moderate CAGR of over 6.1% over the next ten years, and be valued at more than US$ 3.21 Bn by 2030-end. As per product, the demand for nasal steroid spray will remain considerably high, accounting for the leading share in the market though the course of the forecast period.

Future Market Insights (FMI) has forecast positive outlook for the nasal spray market in a recent study. The rising cases of allergic rhinitis and the demand for better accuracy in drug delivery are identified as chief growth drivers. Growth is expected to remain bullish as various countries showcase high healthcare spending.

According to a study by the Research and Development (RAND) Review blog published in 2017, nearly 60% of Americans have at least one chronic health condition, which often results in accelerating healthcare spending each year. With the incidence of chronic ailments and resultant spending on healthcare projected to spur, nasal sprays market will have positive growth on cards.

As per the report, the market’s overall valuation is likely to surpass US$ 15 Bn by 2021. Growth will continue at a positive rate, thanks to recent approvals to nasal migraine and hormonal therapies.

Among products available, nasal steroid spray will prove exceptionally lucrative, accounting for over 42% of sales in the market. Besides their improving availability, potential to offer relief from nasal allergies and  hay fever will drive growth in the category

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-13112

Key Players:

• Astra Zeneca  Plc.
• Cipla Ltd.
• Johnson & Johnson Services, Inc. (Johnson & Johnson Pacific Pty Limited)
• Glaxosmithkline Plc.
• Novartis International AG
• Procter & Gamble
• Sanofi S.A. (Sanofi-aventis LLC.)
• Boehringer Ingelheim GmbH
• AdvaCare Pharma
• Bayer AG (Bayer Consumer Health
• Covis Pharma S.a.r.l.
• Nipro Corporation (NIPRO JMI Pharma Ltd.)
• Viatris Inc. (Meda Pharmaceuticals Inc.)
• Perrigo Company plc
• AptarGroup, Inc.
• Berry Global, Inc.
• URSATEC GmbH
• Gerresheimer AG
• Bona
• Avantor, VWR International, LLC
• Spectrum Laboratory Products, Inc.  (Spectrum Pharmacy Products)
• SKS Bottle & Packaging, Inc.
• Coster Tecnologie Speciali S.p.A

Key Takeaways from Nasal Spray Market Study   

• Rising at above 6% CAGR between 2021 and 2031, nasal sprays market will report consistent surge in demand
• The market in the U.S. is projected to a fast-growing one, accounting for more than 90% share in the North America market
• Government spending on healthcare has created a conducive environment for growth in the U.K.
• Germany will emerge as a leading market for nasal sprays sales in Europe backed by increasing healthcare spending and presence of leading manufacturers
• Focus on health and wellness will continue rising in Japan and South Korea, driving nasal spray sales in East Asia

Ask from the Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-13112

Government Initiatives toward Nasal Spray Consumption

Governmental support for ongoing clinical research, consumption of Nasal Spray, and restricting misuse have favoured growth in demand for Nasal Spray. For instance, there has been a call for rise in production capacity of budesonide nasal spray which shortens COVID19 recovery time.

Since, nasal sprays are also used for depression patients, the market is likely to grow highly.

Who is Winning?

Nasal spray manufacturers with patented drugs are successfully allocating their distribution rights to local companies that are operational in the pain management business. This strategy provides momentum to the growth of these companies’ business, owing to strong demand for generic drugs.

For instance, In November 2019, Sandoz announced that it has entered into a binding agreement for the planned acquisition of the Japanese business of Aspen Global Incorporated (AGI), a wholly owned subsidiary of Aspen Pharmacare Holdings Limited.

Nasal Spray Market by Category

Product

• Decongestant Sprays
• Nasal Steroid Sprays
• Nasal Antihistamine Sprays
• Nasal Cromolyn Sodium Sprays
• Nasal Anticholinergic Sprays
• Nasal Triamcinolone Sprays

Formulation

• Aqueous
• Hydroalcoholic
• Nonaqueous-Based Solution
• Suspension
• Emulsions
• Dry Powder/Micro particles

Packaging

• Pressurized Canisters
• Pump Bottles

 Distribution Channel

• Institutional Sales
  • Hospitals
  • Community Clinics
  • Specialty Clinics
  • Public Health Agencies
  • Veterinary Hospitals & Clinics
• Retail Sales
  • Retail Pharmacies
  • Drug Stores
  • Mail Order Pharmacy

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13112

Region

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• MEA

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/

“